Susan Jeffrey

Allopurinol failed to affect a composite of nonfatal MI, nonfatal stroke, or CV death, in a randomized trial that was ‘definitively neutral’ in patients with heart disease but no gout.

Antiplatelet agent indobufen was noninferior to aspirin in combination with clopidogrel after coronary intervention on both efficacy and safety outcomes, with less mostly minor bleeding.

After a positive FDA panel review in August, the FDA has approved the Paradise Ultrasound Renal Denervation system for the treatment of hypertension, manufacturer Recor and parent company Otsuka announced.

Blood Pressure Lowering Reduces Dementia Risk

Preliminary results of the pivotal phase 3 trial show benefit of the cardiac myosin inhibitor, aficamten, in obstructive hypertrophic cardiomyopathy.